首页> 外文期刊>Journal of Environmental Radioactivity >The influence on the radioxenon background during the temporary suspension of operations of three major medical isotope production facilities in the Northern Hemisphere and during the start-up of another facility in the Southern Hemisphere
【24h】

The influence on the radioxenon background during the temporary suspension of operations of three major medical isotope production facilities in the Northern Hemisphere and during the start-up of another facility in the Southern Hemisphere

机译:在北半球三个主要医学同位素生产设施暂时停止运营以及在南半球启动另一个设施期间,对放射性氙背景的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Medical isotope production facilities (MIPF) have recently been identified to emit the major part of the environmental radioxenon measured at many globally distributed monitoring sites deployed to strengthen the radionuclide component of the Comprehensive Nuclear-Test-Ban Treaty (CTBT) verification regime. Efforts to raise a global radioxenon emission inventory revealed that the yearly global total emission from MIPF's is around 15 times higher than the total radioxenon emission from nuclear power plants (NPP's).rnGiven that situation, from mid 2008 until early 2009 two out of the ordinary hemisphere-specific events occured:rn1) In the Northern hemisphere, a joint temporary suspension of operations of the three largest MIPF's made it possible to quantify the effects of the emissions related to NPP's. The average activity concentrations of ~(133)Xe measured at a monitoring station close to Freiburg, Germany, went down significantly from 4.5 ± 0.5 mBq/m~3 to 1.1 ± 0.1 mBq/m~3 and in Stockholm, Sweden, from 2.0 ± 0.4 mBq/m~3 to 1.05 ± 0.15 mBq/m~3.rn2) In the Southern hemisphere the only radioxenon-emitting MIPF in Australia started up test production in late November 2008. During eight test runs, up to 6.2 ± 0.2 mBq/m~3 of ~(133)Xe was measured at the station in Melbourne, 700 km south-west from the facility, where no radioxenon had been observed before, originating from the isotopic production process.rnThis paper clearly confirms the hypothesis that medical isotope production facility are at present the major emitters of radioxenon to the atmosphere. Suspension of operations of these facilities indicates the scale of their normal contribution to the European radioxenon background, which decreased two to four fold. This also gives a unique opportunity to detect and investigate the influence of other local and long distance sources on the radioxenon background. Finally the opposing effect was studied: the contribution of the start-up of a renewed radiopharmaceutical facility to the build up of a radioxenon background across Australia and the Southern hemisphere.
机译:最近已经确定了医用同位素生产设施(MIPF),其排放的环境放射性氙主要来自许多全球分布的监测点,这些监测点部署用于加强《全面禁止核试验条约》(CTBT)核查制度的放射性核素成分。努力提高全球放射性氙的排放量清单显示,MIPF的年度全球总排放量约为核电厂(NPP)的总氙量的15倍。rn考虑到这种情况,从2008年中至2009年初,有两种异常发生了特定于半球的事件:rn1)在北半球,三个最大的MIPF联合暂停运行使得量化与NPP相关的排放的影响成为可能。在德国弗赖堡附近的监测站测得的〜(133)Xe平均活动浓度从4.5±0.5 mBq / m〜3显着下降至1.1±0.1 mBq / m〜3,在瑞典斯德哥尔摩从2.0 ±0.4 mBq / m〜3到1.05±0.15 mBq / m〜3.rn2)在南半球,澳大利亚唯一的放射出氙气的MIPF于2008年11月下旬开始试生产。在八次试运行中,最高为6.2±0.2 〜(133)Xe的mBq / m〜3在距设施西南700 km的墨尔本站处测量,该站以前从未观察到放射性氙,这是由于同位素生产过程引起的.rn本文明确证实了以下假设医学同位素生产设备是目前向大气排放放射性氙的主要排放源。这些设施的暂停运行表明它们对欧洲放射性氙背景的正常贡献规模减少了2-4倍。这也为检测和调查其他本地和长距离辐射源对放射性氙背景的影响提供了独特的机会。最后,研究了相反的影响:新的放射性药物设施的启动对整个澳大利亚和南半球放射性氙背景的建立的贡献。

著录项

  • 来源
    《Journal of Environmental Radioactivity》 |2010年第9期|P.730-738|共9页
  • 作者单位

    Vienna University of Technology, Atomic Institute of the Austrian Universities, Stadionallee 2, 1020 Vienna, Austria;

    rnBundesamt fuer Strahlenschutz, (BfS), Rosastr. 9, 79098 Freiburg, Germany;

    rnPreparatory Commission for the Comprehensive Nuclear-Test-Ban Treaty Organisation (CTBTO), Provisional Technical Secretariat, PO Box 1200, 1400 Vienna, Austria;

    rnAustralian Nuclear Science and Technology Organisation (ANSTO) Safety and Radiation Protection, Environmental Monitoring, PMB1,2234 Menai, NSW, Australia;

    rnPreparatory Commission for the Comprehensive Nuclear-Test-Ban Treaty Organisation (CTBTO), Provisional Technical Secretariat, PO Box 1200, 1400 Vienna, Austria;

    rnSwedish Defence Research Agency (FOI), Defence and Security, Systems and Technology Division, 172 90 Stockholm, Sweden;

    rnAustralian Radiation Protection and Nuclear Safety Agency (ARPANSA), 619 Lower Plenty Road, 308S Yallambie, VIC Australia;

    rnBundesamt fuer Strahlenschutz, (BfS), Rosastr. 9, 79098 Freiburg, Germany;

    rnFederal Agency for Nuclear Control (FANC), Ravensteinstraat 36, 1000 Brussel, Belgium;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    CTBT; low-level radioactivity measurements; noble gas monitoring; environmental radioxenon; medical isotope production facilities;

    机译:全面禁试条约低水平放射性测量;稀有气体监测;环境放射性氙医用同位素生产设备;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号